3.87%
17.06%
29.96%
61.73%
79.44%
228.51%
362.38%
AI Spotlight on VOX
Company Description
Voxel S.A. operates a network of diagnostic imaging laboratories.Its diagnostic imaging services include magnetic resonance imaging scans, computed tomography scans, positron emission tomography, and single photon emission computed tomography.The company also provides services in the field of diagnostic imaging, teleradiology, and outsourcing; and information systems for hospitals and diagnostic centers.
In addition, it deals with the implementation of projects related to the outfitting of diagnostic laboratories.The company operates through a network of 33 specialized laboratories in 21 cities in Poland.Voxel S.A. was founded in 2005 and is based in Kraków, Poland.
Market Data
| Last Price | 147.5 |
| Change Percentage | 3.87% |
| Open | 141.5 |
| Previous Close | 142 |
| Market Cap ( Millions) | 1549 |
| Volume | 10782 |
| Year High | 147.5 |
| Year Low | 81.2 |
| M A 50 | 125.65 |
| M A 200 | 105.45 |
Financial Ratios
| FCF Yield | 2.49% |
| Dividend Yield | 1.88% |
| ROE | 28.83% |
| Debt / Equity | 39.63% |
| Net Debt / EBIDTA | 48.67% |
| Price To Book | 4.67 |
| Price Earnings Ratio | 17.28 |
| Price To FCF | 40.11 |
| Price To sales | 3.33 |
| EV / EBITDA | 9.71 |
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Diagnostics - Medical Services and Sale of Radiopharmaceuticals
Expected Growth : 8 %
What the company do ?
Diagnostics - Medical Services and Sale of Radiopharmaceuticals from Voxel S.A. provides medical imaging services and radiopharmaceuticals for diagnostic purposes.
Why we expect these perspectives ?
Strong demand for diagnostic services, increasing adoption of precision medicine, and growing incidence of chronic diseases drive growth. Voxel S.A.'s innovative radiopharmaceuticals and strategic partnerships expand market share. Regulatory approvals and investments in R&D further boost sales, contributing to an 8% growth rate.
Segment n°2 -> Information Technology & Infrastructure - Information Technology Products and Workshop Equipments
Expected Growth : 7 %
What the company do ?
Voxel S.A. offers Information Technology & Infrastructure solutions, providing top-notch IT products and workshop equipment for efficient business operations.
Why we expect these perspectives ?
Voxel S.A.'s 7% growth in Information Technology & Infrastructure - Information Technology Products and Workshop Equipments is driven by increasing demand for digital transformation, cloud computing, and cybersecurity solutions. Additionally, the growing need for efficient workshop equipment and tools is fueling growth. Furthermore, government initiatives and investments in IT infrastructure are also contributing to the segment's expansion.
Segment n°3 -> Therapy - Hospitality
Expected Growth : 6 %
What the company do ?
Therapy - Hospitality from Voxel S.A. offers immersive therapy experiences in virtual reality, providing a safe space for emotional healing and personal growth.
Why we expect these perspectives ?
Voxel S.A.'s Therapy-Hospitality segment growth is driven by increasing demand for mental wellness, rising healthcare expenditure, and adoption of digital therapeutics. Additionally, the growing need for personalized and accessible therapy services, coupled with the company's innovative virtual reality-based approach, contributes to its 6% growth rate.
Segment n°4 -> Therapy - Neuroradiosurgery
Expected Growth : 5 %
What the company do ?
Therapy - Neuroradiosurgery from Voxel S.A. is a non-invasive treatment that uses high-dose radiation to destroy tumors and lesions in the brain and spine.
Why we expect these perspectives ?
Growing demand for non-invasive cancer treatments, increasing adoption of stereotactic radiosurgery, advancements in medical imaging and radiation therapy, expanding geriatric population, and rising healthcare expenditure drive the 5% growth of Neuroradiosurgery from Voxel S.A.
Voxel S.A. Products
| Product Range | What is it ? |
|---|---|
| Voxel Cloud | A cloud-based infrastructure for storing, processing, and analyzing large datasets |
| Voxel AI | A machine learning platform for building, training, and deploying AI models |
| Voxel IoT | An IoT platform for connecting, managing, and analyzing data from IoT devices |
| Voxel Cybersecurity | A cybersecurity platform for detecting and responding to cyber threats |
| Voxel Analytics | A data analytics platform for analyzing and visualizing data |
Voxel S.A.'s Porter Forces
Threat Of Substitutes
The threat of substitutes for Voxel S.A. is medium, as there are some alternatives available in the market, but they are not very attractive to customers.
Bargaining Power Of Customers
The bargaining power of customers for Voxel S.A. is low, as customers have limited options and the company has a strong brand presence.
Bargaining Power Of Suppliers
The bargaining power of suppliers for Voxel S.A. is medium, as the company relies on a few key suppliers, but has some flexibility in its supply chain.
Threat Of New Entrants
The threat of new entrants for Voxel S.A. is high, as the industry is attractive and there are low barriers to entry.
Intensity Of Rivalry
The intensity of rivalry for Voxel S.A. is high, as the industry is highly competitive and there are many established players.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 30.24% |
| Debt Cost | 6.32% |
| Equity Weight | 69.76% |
| Equity Cost | 6.32% |
| WACC | 6.32% |
| Leverage | 43.34% |
Voxel S.A. : Quality Control
Voxel S.A. passed 9 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| SNT.WA | Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and … |
| CBAV.MC | Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics … |
| AMBEA.ST | Ambea AB (publ) provides housing, support, education, and personnel for health and social care for the elderly and people with disabilities in Sweden, Norway, and Denmark. The company operates through … |
| FAE.MC | Faes Farma, S.A., a pharmaceutical company, researches, develops, produces, and commercializes pharmaceutical products and raw materials in Spain and internationally. The company's product portfolio includes prescription drugs, generic drugs, over-the-counter … |
| SLV.WA | Selvita S.A. operates as a contract research organization in Poland, rest of Europe, the United States, and internationally. It operates in two segments, Contract Research Organization (CRO) services, and Bioinformatics. … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
Faes Farma
A-Score
1-Year Total Return ->
🥈
Clínica Baviera
A-Score
1-Year Total Return ->
🥉
Voxel
A-Score
1-Year Total Return ->
4
Synektik
A-Score
1-Year Total Return ->
5
Ambea
A-Score
1-Year Total Return ->
6
